Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Aktiengesellschaft Bayer currently holds 12,675,838 shares of Century Therapeutics, Inc. (IPSC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aktiengesellschaft Bayer has been a net buyer of IPSC stock. They have purchased $27.0M and sold $0 worth of shares.
Aktiengesellschaft Bayer's most recent insider trade was on Jun 22, 2021, when they purchased 750,000 shares at $20.00 per share.
Aktiengesellschaft Bayer serves as Executive at Century Therapeutics, Inc. (IPSC). They have executed 4 insider transactions totaling $27.0M over their tenure at the company.
Aktiengesellschaft Bayer holds the position of Executive at Century Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Aktiengesellschaft Bayer has shown a buying trading pattern, with $27.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Aktiengesellschaft Bayer was on Jun 22, 2021, when they purchased $15.0M worth of IPSC shares. This transaction involved 750,000 shares at $20.00 per share.
Aktiengesellschaft Bayer currently owns 12,675,838 shares of Century Therapeutics, Inc. (IPSC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Aktiengesellschaft Bayer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aktiengesellschaft Bayer has 4 Form 4 filings on record as an insider at Century Therapeutics, Inc..
Set alerts for Aktiengesellschaft Bayer and 40,000+ other insiders.